Codexis Inc (CDXS)
3.56
-0.36
(-9.18%)
USD |
NASDAQ |
May 06, 16:00
3.57
+0.01
(+0.28%)
Pre-Market: 09:00
Codexis Revenue (Quarterly): 17.07M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 17.07M |
| December 31, 2023 | 26.56M |
| September 30, 2023 | 9.277M |
| June 30, 2023 | 21.32M |
| March 31, 2023 | 12.98M |
| December 31, 2022 | 30.38M |
| September 30, 2022 | 34.47M |
| June 30, 2022 | 38.41M |
| March 31, 2022 | 35.34M |
| December 31, 2021 | 24.50M |
| September 30, 2021 | 36.77M |
| June 30, 2021 | 25.45M |
| March 31, 2021 | 18.03M |
| December 31, 2020 | 21.03M |
| September 30, 2020 | 18.38M |
| June 30, 2020 | 14.97M |
| March 31, 2020 | 14.67M |
| December 31, 2019 | 18.65M |
| September 30, 2019 | 21.91M |
| June 30, 2019 | 12.32M |
| March 31, 2019 | 15.58M |
| December 31, 2018 | 16.07M |
| September 30, 2018 | 16.95M |
| June 30, 2018 | 13.54M |
| March 31, 2018 | 14.04M |
| Date | Value |
|---|---|
| December 31, 2017 | 21.72M |
| September 30, 2017 | 9.984M |
| June 30, 2017 | 10.35M |
| March 31, 2017 | 7.971M |
| December 31, 2016 | 9.969M |
| September 30, 2016 | 14.87M |
| June 30, 2016 | 16.00M |
| March 31, 2016 | 7.996M |
| December 31, 2015 | 11.59M |
| September 30, 2015 | 17.40M |
| June 30, 2015 | 6.018M |
| March 31, 2015 | 6.798M |
| December 31, 2014 | 14.19M |
| September 30, 2014 | 7.472M |
| June 30, 2014 | 6.57M |
| March 31, 2014 | 7.074M |
| December 31, 2013 | 9.525M |
| September 30, 2013 | 3.943M |
| June 30, 2013 | 6.974M |
| March 31, 2013 | 11.48M |
| December 31, 2012 | 7.912M |
| September 30, 2012 | 26.34M |
| June 30, 2012 | 22.91M |
| March 31, 2012 | 31.14M |
| December 31, 2011 | 33.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.277M
Minimum
Sep 2023
38.41M
Maximum
Jun 2022
22.62M
Average
21.18M
Median
Revenue (Quarterly) Benchmarks
| Avidity Biosciences Inc | 2.193M |
| Taysha Gene Therapies Inc | 3.604M |
| Janux Therapeutics Inc | 2.461M |
| Tango Therapeutics Inc | 5.431M |
| 2seventy bio Inc | 10.68M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.50M |
| Total Expenses (Quarterly) | 28.96M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | 193.77M |
| Gross Profit Margin (Quarterly) | 71.56% |
| Profit Margin (Quarterly) | -67.39% |
| Earnings Yield | -26.12% |
| Normalized Earnings Yield | -21.91 |